美国食品药品监督管理局不良事件报告系统（FAERS）数据库中更极端的重复情况以及不成比例分析的建议检查点。 - Suppr

Suppr

超能文献

More extreme duplication in the U.S. FDA FAERS database and a suggested check point for disproportionality analysis.

作者信息

Hauben Manfred, Zou Chen, Bright Steve, Hung Eric

机构信息

Department of Medicine, NYU Langone Health, New York, New York, USA.

Safety Surveillance and Risk Management, Pfizer Inc., New York, New York, USA.

出版信息

Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1140-1141. doi: 10.1002/pds.5265. Epub 2021 May 13.

DOI:10.1002/pds.5265

PMID:33960586

Abstract

摘要

相似文献

More extreme duplication in the U.S. FDA FAERS database and a suggested check point for disproportionality analysis.美国食品药品监督管理局不良事件报告系统（FAERS）数据库中更极端的重复情况以及不成比例分析的建议检查点。

Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1140-1141. doi: 10.1002/pds.5265. Epub 2021 May 13.

Comment on: "Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database".关于《美国市售癌症支持性护理生物类似药的安全性：使用食品药品监督管理局不良事件报告系统（FAERS）数据库的不成比例性分析》的评论

BioDrugs. 2021 May;35(3):373-374. doi: 10.1007/s40259-021-00476-9. Epub 2021 Apr 16.

Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.氨磺必利的新型不良事件：美国食品药品监督管理局不良事件报告系统（FAERS）数据库中的不成比例性分析。

Curr Drug Saf. 2019;14(1):21-26. doi: 10.2174/1574886313666181026100000.

Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.在 FDA 不良事件报告系统 (FAERS) 数据库中分析药物性肝损伤的累积比例报告比值。

Drug Saf. 2013 Dec;36(12):1169-78. doi: 10.1007/s40264-013-0116-9.

Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.药物相关性急性肾损伤在美国食品和药物管理局不良事件报告系统数据库中的识别。

Pharmacotherapy. 2018 Aug;38(8):785-793. doi: 10.1002/phar.2152. Epub 2018 Jul 13.

Author's Reply to Joerg Putzke et al. Comment on: "Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database".作者对约尔格·普茨克等人的回复。评论：“美国上市的癌症支持性护理生物类似药的安全性：使用美国食品药品监督管理局不良事件报告系统（FAERS）数据库进行的不成比例性分析”

BioDrugs. 2021 May;35(3):375-377. doi: 10.1007/s40259-021-00474-x. Epub 2021 Apr 16.

Hypnotics and infections: disproportionality analysis of the U.S. Food & Drug Administration adverse event reporting system database.催眠药物和感染：美国食品和药物管理局不良事件报告系统数据库的比例失调分析。

J Clin Sleep Med. 2022 Sep 1;18(9):2229-2235. doi: 10.5664/jcsm.10094.

The Weber effect and the United States Food and Drug Administration's Adverse Event Reporting System (FAERS): analysis of sixty-two drugs approved from 2006 to 2010.韦伯效应与美国食品药品监督管理局不良事件报告系统（FAERS）：对2006年至2010年批准的62种药物的分析

Drug Saf. 2014 Apr;37(4):283-94. doi: 10.1007/s40264-014-0150-2.

Investigating Overlap in Signals from EVDAS, FAERS, and VigiBase.调查 EVDAS、FAERS 和 VigiBase 信号中的重叠。

Drug Saf. 2020 Apr;43(4):351-362. doi: 10.1007/s40264-019-00899-y.

'Extreme duplication' in the US FDA Adverse Events Reporting System database.美国食品药品监督管理局不良事件报告系统数据库中的“极度重复”现象。

Drug Saf. 2007;30(6):551-4. doi: 10.2165/00002018-200730060-00009.

引用本文的文献

Post-marketing safety signals of imatinib: pharmacovigilance insights from the FDA Adverse Event Reporting System (FAERS) and implications for clinical practice.伊马替尼的上市后安全信号：来自美国食品药品监督管理局不良事件报告系统（FAERS）的药物警戒见解及其对临床实践的影响。

Eur J Clin Pharmacol. 2025 Jul 8. doi: 10.1007/s00228-025-03872-0.

An Evaluation of Duplicate Adverse Event Reports Characteristics in the Food and Drug Administration Adverse Event Reporting System.食品药品监督管理局不良事件报告系统中重复不良事件报告特征的评估

Drug Saf. 2025 Jun 4. doi: 10.1007/s40264-025-01560-7.

Postmarketing safety evaluation of pemetrexed using FAERS and JADER databases.使用FAERS和JADER数据库对培美曲塞进行上市后安全性评估。

Sci Rep. 2025 May 28;15(1):18738. doi: 10.1038/s41598-025-02426-9.

FDA Adverse Event Reporting System (FAERS) Essentials: A Guide to Understanding, Applying, and Interpreting Adverse Event Data Reported to FAERS.美国食品药品监督管理局不良事件报告系统（FAERS）要点：解读、应用及阐释向FAERS报告的不良事件数据指南

Clin Pharmacol Ther. 2025 Sep;118(3):567-582. doi: 10.1002/cpt.3701. Epub 2025 May 19.

Reply: [Post-marketing safety concerns with Lecanemab: a disproportionality analysis using the FDA adverse event reporting system].回复：[仑卡奈单抗的上市后安全性问题：使用美国食品药品监督管理局不良事件报告系统的不成比例性分析]

Alzheimers Res Ther. 2025 Apr 8;17(1):77. doi: 10.1186/s13195-025-01728-4.

Adverse events reporting of Etelcalcetide: a real-word analysis from FAERS database.依替卡肽的不良事件报告：来自FAERS数据库的真实世界分析。

J Pharm Policy Pract. 2025 Mar 31;18(1):2479072. doi: 10.1080/20523211.2025.2479072. eCollection 2025.

Finasteride Use: Evaluation of Depression and Suicide Risk.非那雄胺的使用：抑郁和自杀风险评估

J Cosmet Dermatol. 2025 Mar;24(3):e70102. doi: 10.1111/jocd.70102.

Commentary: Adverse event profiles of PARP inhibitors: analysis of spontaneous reports submitted to FAERS.评论：PARP抑制剂的不良事件概况：对提交给FAERS的自发报告的分析

Front Pharmacol. 2023 Aug 16;14:1241524. doi: 10.3389/fphar.2023.1241524. eCollection 2023.

A real-world pharmacovigilance study of abaloparatide based on the FDA Adverse Event Reporting System (FAERS).基于 FDA 不良事件报告系统（FAERS）的阿巴洛肽真实世界药物警戒研究。

Osteoporos Int. 2023 Dec;34(12):2047-2058. doi: 10.1007/s00198-023-06877-6. Epub 2023 Aug 18.

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib.尼拉帕利的真实世界药物警戒研究：美国食品药品监督管理局不良事件报告系统（FAERS）事件。

Sci Rep. 2022 Nov 29;12(1):20601. doi: 10.1038/s41598-022-23726-4.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验